Conkiss: Conformal Kidneys Sparing 3D Noncoplanar Radiotherapy Treatment for Pancreatic Cancer As an Alternative to IMRT

Medical Dosimetry

Volumn 36, Issue 1, 2011, Pages 35-40

  Sebestyén, Zsolt ^a   Kovács, Péter ^a   Gulybán, Akos ^b   Farkas, Róbert ^a   Bellyei, Szabolcs ^a   Liposits, Gábor ^a   Szigeti, András ^a   Ésik, Olga ^a   Dérczy, Katalin ^a   Mangel, László ^a  

^a UNIVERSITY OF PÉCS   (Hungary)

^b EORTC DATA CENTER   (Belgium)

Author keywords

3D conformal radiotherapy; Dosimetric comparison; IMRT; Noncoplanar fields; Pancreatic cancer

Indexed keywords

ALGORITHM; ANTERIOR POSTERIOR AXIS; ARTICLE; CANCER RADIOTHERAPY; CLINICAL ARTICLE; COMPUTER ASSISTED RADIOTHERAPY; HUMAN; INTENSITY MODULATED RADIATION THERAPY; KIDNEY; LIVER; PANCREAS CANCER; PRIORITY JOURNAL; RADIATION BEAM; RADIATION DOSE DISTRIBUTION; RADIATION EXPOSURE; RADIATION HAZARD; RETROSPECTIVE STUDY; SPINAL CORD; THREE DIMENSIONAL IMAGING; TREATMENT PLANNING;

ALGORITHMS; COMPUTER SIMULATION; HUMANS; KIDNEY; MODELS, BIOLOGICAL; PANCREATIC NEOPLASMS; RADIATION PROTECTION; RADIOMETRY; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, CONFORMAL;

EID: 79551607378     PISSN: 09583947     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.meddos.2009.11.001     Document Type: Article

References (25)

1. Brade A., Brierley J., Oza A., et al. Concurrent gemcitabine and radiotherapy with and without neoadjuvant gemcitabine for locally advanced unresectable or resected pancreatic cancer: a phase I-II study. Int. J. Radiat. Oncol. Biol. Phys. 2007, 67:1027-1036.
2. Jemal A., Siegel R., Ward E., et al. Cancer statistics, 2008. CA. Cancer. J. Clin 2008, 58:71-96.
3. Ko A.H., Quivey J.M., Venook A.P., et al. A phase II study of fixed-dose rate gemcitabine plus low-dose cisplatin followed by consolidative chemoradiation for locally advanced pancreatic cancer. Int. J. Radiat. Oncol. Biol. Phys. 2007, 68:809-816.
4. Keene K.S., Rich T.A., Penberthy D.R., et al. Clinical experience with chronomodulated infusional 5-fluorouracil chemoradiotherapy for pancreatic adenocarcinoma. Int. J. Radiat. Oncol. Biol. Phys. 2005, 62:97-103.
5. Murphy J.D., Adusumilli S., Griffith K.A., et al. Full-dose gemcitabine and concurrent radiotherapy for unresectable pancreatic cancer. Int. J. Radiat. Oncol. Biol. Phys. 2007, 68:801-808.
6. Ben-Josef E., Shields A.F., Vaishampayan U., et al. Intensity modulated radiotherapy (IMRT) and concurrent capecitabine for pancreatic cancer. Int. J. Radiat. Oncol. Biol. Phys. 2004, 59:454-459.
7. Spry N., Harvey J., MacLeod C., et al. 3D Radiotherapy can be safely combined with sandwich systemic gemcitabine chemotherapy in the management of pancreatic cancer: Actors influencing outcome. Int. J. Radiat. Oncol. Biol. Phys. 2008, 70:1438-1446.
8. Dobbs J., Barrett A., Ash D. Practical radiotherapy planning 1999, 247-252. Arnold and Oxford University Press, Bristol. 3rd ed.
9. Brown M.W., Ning H., Arora B., et al. A dosimetric analysis of dose escalation using two intensity-modulated radiation therapy techniques in locally advanced pancreatic carcinoma. Int. J. Radiat. Oncol. Biol. Phys. 2006, 65:274-283.
10. Prescribing, recording, and reporting photon beam therapy. Report 50 1993, ICRU, International Commission on Radiation Units and Measurements, Bethesda, MD.
11. Prescribing and reporting photon beam therapy. Report 62 1999, ICRU, International Commission on Radiation Units and Measurements, Washington D.C.
12. Wilkowski R., Thoma M., Weingandt H., et al. Chemoradiation for ductal pancreatic carcinoma: Principles of combining chemotherapy with radiation, definition of target volume and radiation dose [review]. JOP 2005, 6:216-230.
13. Dawson L.A., Ten Haken R.K., Lawrence T.S. Partial irradiation of the liver [abstract]. Semin. Radiat. Oncol. 2001, 11:240-246.
14. Gulyban A. Kovács P., Sebestyén Z., et al. Multisegmented tangential breast fields: A rational way to treat breast cancer. Strahlenther. Oncol. 2008, 184:262-269.
15. Van't Riet A., Mak A.C., Moerland M.A., et al. A conformation number to quantify the degree of conformity in brachytherapy and external irradiation: Application to the prostate. Int. J. Radiat. Oncol. Biol. Phys. 1997, 37:731-736.
16. Feuvret L., Noel G., Mazeron J.J., et al. Conformity index: A review. Int. J. Radiat. Oncol. Biol. Phys. 2006, 64:333-342.
17. Van Asselen B., Raaijmakers C.P.J., Hofman P., et al. An improved breast irradiation technique using three-dimensional geometrical information and intensity modulation. Radiother. Oncol. 2001, 58:341-347.
18. Hsiung-Stripp D.C., McDonough J., Masters H.M., et al. Comparative treatment planning between proton and X-ray therapy in pancreatic cancer. Med. Dosim 2001, 26:255-259.
19. Menhel J., Levin D., Alezra D., et al. Assessing the quality of conformal treatment planning: A new tool for quantitative comparison. Phys. Med. Biol 2006, 51:5363-5375.
20. Lomax N.J., Scheib S.G. Quantifying the degree of conformity in radiosurgery treatment planning. Int. J. Radiat. Oncol. Biol. Phys. 2003, 55:1409-1419.
21. Weber D.C., Trofimov A.V., Delaney T.F., et al. A treatment planning comparison of intensity modulated photon and proton therapy for paraspinal sarcomas. Int. J. Radiat. Oncol. Biol. Phys. 2004, 58:1596-1606.
22. Higgins P.D., Sohn J.W., Fine R.M., et al. Three-dimensional conformal pancreas treatment: Comparison of four- to six-field techniques [abstract]. Int. J. Radiat. Oncol. Biol. Phys. 1995, 31:605-609.
23. Osborne C., Bydder S.A., Ebert M.A., et al. Comparison of non-coplanar and coplanar techniques to treat cancer of the pancreas. Australas. Radiol 2006, 50:463-467.
24. Bussels B., Goethals L., Feron M., et al. Respiration-induced movement of the upper abdominal organs: A pitfall for the three-dimensional conformal radiation treatment of pancreatic cancer. Radiother. Oncol 2003, 68:69-74.
25. Gierga D.P., Chen G.T.Y., Kung J.H., et al. Quantification of respiration-induced abdominal tumor motion and its impact on IMRT dose distributions. Int. J. Radiat. Oncol. Biol. Phys. 2004, 58:1584-1595.